| scholarly article | Q13442814 |
| P8978 | DBLP publication ID | journals/neuroimage/MaTME09 |
| P356 | DOI | 10.1016/J.NEUROIMAGE.2008.09.052 |
| P932 | PMC publication ID | 2946847 |
| P698 | PubMed publication ID | 18992824 |
| P5875 | ResearchGate publication ID | 23459894 |
| P50 | author | David Eidelberg | Q5233311 |
| James R. Moeller | Q67409205 | ||
| Chengke Tang | Q125216967 | ||
| P2093 | author name string | Yilong Ma | |
| P2860 | cites work | Confounded correlations: statistical limitations in the analysis of interregional relationships of cerebral metabolic activity | Q48337353 |
| Divergent expression of regional metabolic topographies in Parkinson's disease and normal ageing | Q48552859 | ||
| Bayesian decoding of brain images. | Q51904450 | ||
| Normalization in PET group comparison studies--the importance of a valid reference region. | Q53436547 | ||
| The metabolic topography of parkinsonism | Q72136177 | ||
| Assessment of disease severity in parkinsonism with fluorine-18-fluorodeoxyglucose and PET | Q72616594 | ||
| Template images for nonhuman primate neuroimaging: 2. Macaque | Q74377948 | ||
| Staging of brain pathology related to sporadic Parkinson's disease | Q28131702 | ||
| Functional networks in motor sequence learning: abnormal topographies in Parkinson's disease | Q30631959 | ||
| Neuroimaging and therapeutics in movement disorders | Q30989947 | ||
| A new approach to spatial covariance modeling of functional brain imaging data: ordinal trend analysis | Q30990108 | ||
| Assessment of the progression of Parkinson's disease: a metabolic network approach | Q31130371 | ||
| Statistical limitations in functional neuroimaging. I. Non-inferential methods and statistical models | Q33178818 | ||
| A regional covariance approach to the analysis of functional patterns in positron emission tomographic data | Q33517520 | ||
| Safety and tolerability of gene therapy with an adeno-associated virus (AAV) borne GAD gene for Parkinson's disease: an open label, phase I trial | Q34640765 | ||
| Thalamic metabolism and symptom onset in preclinical Huntington's disease | Q34692568 | ||
| Dissociation of metabolic and neurovascular responses to levodopa in the treatment of Parkinson's disease | Q34770504 | ||
| Functional neuroanatomy of the basal ganglia in Parkinson's disease | Q35004651 | ||
| Functional brain imaging in Parkinson's disease | Q35004733 | ||
| Network modulation by the subthalamic nucleus in the treatment of Parkinson's disease | Q35679727 | ||
| Changes in network activity with the progression of Parkinson's disease | Q35679748 | ||
| Abnormal metabolic network activity in Parkinson's disease: test-retest reproducibility. | Q35683286 | ||
| Metabolic brain networks associated with cognitive function in Parkinson's disease | Q35684482 | ||
| Network modulation in the treatment of Parkinson's disease | Q35694166 | ||
| Modulation of metabolic brain networks after subthalamic gene therapy for Parkinson's disease | Q36288717 | ||
| Scaled subprofile model: a statistical approach to the analysis of functional patterns in positron emission tomographic data | Q36460668 | ||
| Reciprocal Benefits of Mass-Univariate and Multivariate Modeling in Brain Mapping: Applications to Event-Related Functional MRI, H(2) (15)O-, and FDG-PET | Q36572483 | ||
| Multivariate and univariate neuroimaging biomarkers of Alzheimer's disease | Q36739358 | ||
| Metabolic correlates of pallidal neuronal activity in Parkinson's disease | Q39453972 | ||
| Principal component analysis and the scaled subprofile model compared to intersubject averaging and statistical parametric mapping: I. "Functional connectivity" of the human motor system studied with [15O]water PET. | Q40974184 | ||
| Calculating correlation coefficients with repeated observations: Part 1--Correlation within subjects | Q41972849 | ||
| The metabolic topography of normal aging | Q42629288 | ||
| Networks mediating the clinical effects of pallidal brain stimulation for Parkinson's disease: a PET study of resting-state glucose metabolism | Q43679905 | ||
| The metabolic substrates of bradykinesia and tremor in uncomplicated Parkinson's disease | Q44177590 | ||
| Artefactual subcortical hyperperfusion in PET studies normalized to global mean: lessons from Parkinson's disease | Q44418055 | ||
| PET imaging of implanted human retinal pigment epithelial cells in the MPTP-induced primate model of Parkinson's disease | Q45068388 | ||
| Subthalamic glutamic acid decarboxylase gene therapy: changes in motor function and cortical metabolism | Q45859700 | ||
| Levodopa-induced dyskinesia in MPTP-treated macaques is not dependent on the extent and pattern of nigrostrial lesioning. | Q46608469 | ||
| Metabolic correlates of subthalamic nucleus activity in Parkinson's disease | Q46653986 | ||
| Abnormal metabolic networks in atypical parkinsonism | Q46815002 | ||
| Learning networks in health and Parkinson's disease: reproducibility and treatment effects. | Q47824726 | ||
| Individual differences in PET activation of object perception and attention systems predict face matching accuracy | Q48103474 | ||
| Reproducibility of regional metabolic covariance patterns: comparison of four populations. | Q48134047 | ||
| Regional metabolic changes in the pedunculopontine nucleus of unilateral 6-hydroxydopamine Parkinson's model rats. | Q48215429 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Parkinson's disease | Q11085 |
| P304 | page(s) | 260-266 | |
| P577 | publication date | 2008-10-18 | |
| P1433 | published in | NeuroImage | Q1981225 |
| P1476 | title | Abnormal regional brain function in Parkinson's disease: truth or fiction? | |
| P478 | volume | 45 |
| Q64108071 | A New Metabolic Network Correlated with Olfactory and Executive Dysfunctions in Idiopathic Rapid Eye Movement Sleep Behavior Disorder |
| Q36326985 | Abnormal network topographies and changes in global activity: absence of a causal relationship |
| Q33835425 | Abnormalities in metabolic network activity precede the onset of motor symptoms in Parkinson's disease |
| Q37355249 | Alternative normalization methods demonstrate widespread cortical hypometabolism in untreated de novo Parkinson's disease. |
| Q38254740 | Brain network markers of abnormal cerebral glucose metabolism and blood flow in Parkinson's disease |
| Q93192834 | Brain-First versus Gut-First Parkinson's Disease: A Hypothesis |
| Q42019841 | Characterization of disease-related covariance topographies with SSMPCA toolbox: effects of spatial normalization and PET scanners |
| Q30940145 | Classification of Parkinsonian syndromes from FDG-PET brain data using decision trees with SSM/PCA features |
| Q91670190 | Correlations of Neuropsychological and Metabolic Brain Changes in Parkinson's Disease and Other α-Synucleinopathies |
| Q42563061 | Dissociable effects of methylphenidate, atomoxetine and placebo on regional cerebral blood flow in healthy volunteers at rest: a multi-class pattern recognition approach |
| Q36426177 | Effects of acute levodopa challenge on resting cerebral blood flow in Parkinson's Disease patients assessed using pseudo-continuous arterial spin labeling. |
| Q58789390 | FDG PET Parkinson's disease-related pattern as a biomarker for clinical trials in early stage disease |
| Q34035765 | FDG PET in the Evaluation of Parkinson's Disease |
| Q64806177 | FDG-PET hypometabolism is more sensitive than MRI atrophy in Parkinson's disease: A whole-brain multimodal imaging meta-analysis |
| Q34308197 | Functional brain networks in movement disorders: recent advances |
| Q35053430 | Functional reorganization of motor and limbic circuits after exercise training in a rat model of bilateral parkinsonism |
| Q64865269 | Hypermetabolism in the cerebellum and brainstem and cortical hypometabolism are independently associated with cognitive impairment in Parkinson's disease |
| Q30655192 | Identification of disease-related spatial covariance patterns using neuroimaging data |
| Q55223963 | Intra- and Inter-scanner Reliability of Scaled Subprofile Model of Principal Component Analysis on ALFF in Resting-State fMRI Under Eyes Open and Closed Conditions. |
| Q42415986 | Muscle co-activity tuning in Parkinsonian hand movement: disease-specific changes at behavioral and cerebral level |
| Q47632627 | Network Structure and Function in Parkinson's Disease. |
| Q34234625 | Neuroimaging: current role in detecting pre-motor Parkinson's disease. |
| Q34433980 | Quantification of indirect pathway inhibition by the adenosine A2a antagonist SYN115 in Parkinson disease. |
| Q36071428 | Reproducibility of a Parkinsonism-related metabolic brain network in non-human primates: A descriptive pilot study with FDG PET. |
| Q33726349 | Scaled subprofile modeling of resting state imaging data in Parkinson's disease: Methodological issues |
| Q34096185 | The metabolic brain network in patients with Parkinson's disease based on (18)F-FDG PET imaging: evaluation of neuronal injury and regeneration. |
| Q48866922 | The value of putaminal diffusion imaging versus 18-fluorodeoxyglucose positron emission tomography for the differential diagnosis of the Parkinson variant of multiple system atrophy |
| Q42952840 | Typical cerebral metabolic patterns in neurodegenerative brain diseases |
| Q47907731 | Validation of parkinsonian disease-related metabolic brain patterns |
Search more.